Latest news on Alzheimer's

The pharmaceutical representatives have had a chance to see first-hand the new equipment of the Pasqual Maragall Foundation’s research center

Lumbar puncture is a procedure to extract cerebrospinal fluid that allows the study of biomarkers of Alzheimer's disease.

From our commitment to transparency, we present the strategic axes and future lines of the Pasqual Maragall Foundation to our participants in studies, partners, collaborators and civil society

On the occasion of the AD / PD 2022 congress, held in Barcelona, ​​the BBRC hosted researchers from all over the world. At the meeting there was a presentation by Prof. Henrik Zetterberg of the University of Gothenburg

This is the AHEAD clinical trial, an international multicenter study to evaluate the efficacy and safety of lecanemab

AD / PD 2022, held this year in Barcelona, ​​presents work carried out at the Pasqual Maragall Foundation’s research center, in three oral presentations and a poster. In addition, one of our researchers will moderate a symposium of the congress

The study's innovative design has allowed researchers to detect that carriers of the apoe-ε4 gene, linked to an increased risk of developing Alzheimer's, have an accumulation of early amyloid protein in the hippocampal area

This has been demonstrated in a study by BBRC researchers, published in Alzheimer's & Dementia, in which they have studied the protective effect against malaise and its link to major volumes of gray matter

The study, which began in May 2018, looked at the risk of developing dementia five years ahead, in people with subjective memory complaints